{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T08:41:36Z","timestamp":1790671296262,"version":"4.1.0"},"reference-count":38,"publisher":"American Association for Cancer Research (AACR)","issue":"4","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2004,2,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The majority of cancer is of surface\/cyst epithelial origin. The ovarian surface epithelial cells are organized by a sheet of basement membrane composed mainly of collagen IV and laminin, and it is believed that the basement membrane greatly influences the physiological properties of ovarian surface epithelial cells. Previous studies in our laboratories indicated that loss of the basement membrane, an obligated step in ovulation, is also a critical step during the morphological transformation and tumor initiation of the ovarian surface epithelium. It is speculated that the loss of basement membrane in ovarian surface epithelial transformation may have similar biological mechanism to the loss of surface epithelial basement membrane in ovulation. However, the mechanisms involved in the ovarian surface epithelial basement membrane removal during ovulation are still not completely understood. In the current study, cultured human ovarian surface epithelial (HOSE) cells were examined for their abilities to produce matrix hydrolyzing enzymes and degrade basement membrane in response to a number of potential local mediators in ovulation. Among the candidate-stimulating factors tested, tumor necrosis factor (TNF)-\u03b1 and IL-1\u03b2 (to a lesser extent) were found to drastically increase urokinase type plasminogen activator (uPA) and matrix metalloproteinase (MMP)-9 activities secreted from HOSE cells. MMP-2, the other major HOSE cell-secreted gelatinase, is constitutively produced but not regulated. As demonstrated by immunofluorenscence staining and Western blot analysis, TNF-\u03b1 treatment caused the degradation and structural reorganization of collagen IV and laminin secreted and deposited by HOSE cells in culture. Amiloride, an uPA inhibitor, not only inhibited the activity of uPA but was also able to suppress TNF-\u03b1-stimulated MMP-9 activity and prevented the TNF-\u03b1-stimulated remodeling of the basement membrane extracellular matrix, suggesting the contribution of uPA-mediated proteolytic cascade in this process. This study implicates the potential roles of TNF-\u03b1, uPA, and MMP-9 in ovarian surface epithelial basement membrane degradation and remodeling, which are processes during ovulation and may contribute to epithelial transformation. The findings may underscore the importance of TNF-\u03b1, uPA, and MMP-9 in ovarian surface epithelial basement membrane remodeling and may provide a molecular mechanism linking ovulation and ovarian cancer risk.<\/jats:p>","DOI":"10.1158\/0008-5472.can-03-2928","type":"journal-article","created":{"date-parts":[[2005,9,20]],"date-time":"2005-09-20T22:37:24Z","timestamp":1127255844000},"page":"1534-1540","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Tumor Necrosis Factor-\u03b1-Induced Matrix Proteolytic Enzyme Production and Basement Membrane Remodeling by Human Ovarian Surface Epithelial Cells"],"prefix":"10.1158","volume":"64","author":[{"given":"Wan-Lin","family":"Yang","sequence":"first","affiliation":[{"name":"Ovarian Cancer and Tumor Biology Programs, Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew K.","family":"Godwin","sequence":"additional","affiliation":[{"name":"Ovarian Cancer and Tumor Biology Programs, Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-Xi","family":"Xu","sequence":"additional","affiliation":[{"name":"Ovarian Cancer and Tumor Biology Programs, Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2004,2,18]]},"reference":[{"key":"2022061620195812300_B1","doi-asserted-by":"crossref","unstructured":"Bell D. A., Scully R. E. Early de novo ovarian carcinoma. A study of fourteen cases. Cancer (Phila.), 73:\u20081859-1864, \u20081994.","DOI":"10.1002\/1097-0142(19940401)73:7<1859::AID-CNCR2820730714>3.0.CO;2-L"},{"key":"2022061620195812300_B2","doi-asserted-by":"crossref","unstructured":"Berchuck A. B., Kohler M. F., Boente M. P., Rodriguez G. C., Whitaker R. S., Bast R. C., Jr. Growth regulation and transformation of ovarian epithelium. Cancer, 71:\u2008545-551, \u20081993.","DOI":"10.1002\/cncr.2820710209"},{"key":"2022061620195812300_B3","doi-asserted-by":"crossref","unstructured":"Auersperg N., Ota T., Mitchell G. W. E. Early events in ovarian epithelial carcinogenesis: progress and problems in experimental approaches. Int. J. Gynecol. Cancer, 12:\u2008691-703, \u20082002.","DOI":"10.1136\/ijgc-00009577-200211000-00002"},{"key":"2022061620195812300_B4","doi-asserted-by":"crossref","unstructured":"Murdoch W. J., McDonnel A. C. Roles of the ovarian surface epithelium in ovulation and carcinogenesis. Reproduction, 123:\u2008743-750, \u20082002.","DOI":"10.1530\/rep.0.1230743"},{"key":"2022061620195812300_B5","doi-asserted-by":"crossref","unstructured":"Stenbeck F., Wasenius V-M. Basement membrane structures in tumors of the ovary. Eur. J. Obstet. Gynecol. Reprod. Biol., 20:\u2008357-371, \u20081985.","DOI":"10.1016\/0028-2243(85)90059-0"},{"key":"2022061620195812300_B6","unstructured":"Timpl R., Dziadek M. Structure, development, and molecular pathology of basement membranes. Int. Rev. Exp. Pathol., 29:\u20081-112, \u20081986."},{"key":"2022061620195812300_B7","doi-asserted-by":"crossref","unstructured":"Auersperg N., Wong A. S., Choi K. C., Kang S. K., Leung P. C. Ovarian surface epithelium: biology, endocrinology, and pathology. Endocr. Rev., 22:\u2008255-288, \u20082001.","DOI":"10.1210\/edrv.22.2.0422"},{"key":"2022061620195812300_B8","doi-asserted-by":"crossref","unstructured":"Adams J. C., Watt F. M. Regulation of development and differentiation by the extracellular matrix. Development, 117:\u20081183-1198, \u20081993.","DOI":"10.1242\/dev.117.4.1183"},{"key":"2022061620195812300_B9","doi-asserted-by":"crossref","unstructured":"Bissell M. J., Barcellos-Hoff M. H. The influence of extracellular matrix on gene expression: is structure the message?. J. Cell Sci., 8:\u2008327-343, \u20081987.","DOI":"10.1242\/jcs.1987.Supplement_8.18"},{"key":"2022061620195812300_B10","doi-asserted-by":"crossref","unstructured":"Kruk P. A., Uitto V-J., Firth J. D., Dedhar S., Auersperg N. Reciprocal interaction between human ovarian surface epithelial cells and adjacent extracellular matrix. Exp. Cell Res., 215:\u200897-108, \u20081994.","DOI":"10.1006\/excr.1994.1320"},{"key":"2022061620195812300_B11","doi-asserted-by":"crossref","unstructured":"Richards J. S., Russell D. L., Ochsner S., Espey L. L. Ovulation: new dimensions and new regulators of the inflammatory-like response. Annu. Rev. Physiol., 64:\u200869-92, \u20082002.","DOI":"10.1146\/annurev.physiol.64.081501.131029"},{"key":"2022061620195812300_B12","doi-asserted-by":"crossref","unstructured":"Tsafriri A., Reich R. Molecular aspects of mammalian ovulation. Exp. Clin. Endocrinol. Diabetes, 107:\u20081-11, \u20081999.","DOI":"10.1055\/s-0029-1212066"},{"key":"2022061620195812300_B13","doi-asserted-by":"crossref","unstructured":"Terranova P. F., Montgomery R. V. Review: cytokine involvement in ovarian processes. Am. J. Reprod. Immunol., 37:\u200850-63, \u20081997.","DOI":"10.1111\/j.1600-0897.1997.tb00192.x"},{"key":"2022061620195812300_B14","doi-asserted-by":"crossref","unstructured":"Brannstrom M., Bonello N., Wang L. J., Norman R. J. Effects of tumor necrosis factor \u03b1 (TNF\u03b1) on ovulation in the rat ovary. Reprod. Fertil. Dev., 7:\u200867-73, \u20081995.","DOI":"10.1071\/RD9950067"},{"key":"2022061620195812300_B15","doi-asserted-by":"crossref","unstructured":"Murdoch W. J., Colgin D. C., Ellis J. A. Role of tumor necrosis factor-\u03b1 in the ovulatory mechanism of ewes. J. Anim. Sci., 75:\u20081601-1605, \u20081997.","DOI":"10.2527\/1997.7561601x"},{"key":"2022061620195812300_B16","doi-asserted-by":"crossref","unstructured":"Kol S., Ruutiainen-Altman K., Scherzer W. J., Ben-Shlomo I., Ando M., Rohan R. M., Adashi E. Y. The rat intraovarian interleukin (IL)-1 system: cellular localization, cyclic variation and hormonal regulation of IL-1beta and of the type I and type II IL-1 receptors. Mol. Cell. Endocrinol., 149:\u2008115-128, \u20081999.","DOI":"10.1016\/S0303-7207(98)00260-3"},{"key":"2022061620195812300_B17","doi-asserted-by":"crossref","unstructured":"Abisogun A. O., Braquet P., Tsafriri A. The involvement of platelet activating factor in ovulation. Science (Wash. DC), 243:\u2008381-383, \u20081989.","DOI":"10.1126\/science.2911750"},{"key":"2022061620195812300_B18","doi-asserted-by":"crossref","unstructured":"Murdoch W. J., Van Kirk E. A., Murdoch W. J. Hormonal control of urokinase plasminogen activator secretion by sheep ovarian surface spithelial cells. Biol. Reprod., 61:\u20081487-1491, \u20081999.","DOI":"10.1095\/biolreprod61.6.1487"},{"key":"2022061620195812300_B19","doi-asserted-by":"crossref","unstructured":"Hagglund A-C., Ny A., Leonardsson G., Ny T. Regulation and localization of matrix metalloproteinases and tissue inhibitors of metalloproteinases in the mouse ovary during gonadotropin-induced ovulation. Endocrinology, 140:\u20084351-4358, \u20081999.","DOI":"10.1210\/endo.140.9.7002"},{"key":"2022061620195812300_B20","doi-asserted-by":"crossref","unstructured":"Colgin D. C., Murdoch W. J. Evidence for a role of the ovarian surface epithelium in the ovulatory mechanism of the sheep: secretion of urokinase-type plasminogen activator. Anim. Reprod. Sci., 47:\u2008197-204, \u20081997.","DOI":"10.1016\/S0378-4320(97)00011-0"},{"key":"2022061620195812300_B21","doi-asserted-by":"crossref","unstructured":"Brannstrom M., Woessner J. F., Jr., Koos R. D., Sear C. H., LeMaire W. J. Inhibitors of mammalian tissue collagenase and metalloproteinases suppress ovulation in the perfused rat ovary. Endocrinology, 122:\u20081715-1721, \u20081988.","DOI":"10.1210\/endo-122-5-1715"},{"key":"2022061620195812300_B22","doi-asserted-by":"crossref","unstructured":"Butler T. A., Zhu C., Mueller R. A., Fuller G. C., LeMaire W. J., Woessner J. E., Jr. Inhibition of ovulation in the perfused rat ovary by the synthetic collagenase inhibitor SC44463. Biol. Reprod., 44:\u20081183-1188, \u20081991.","DOI":"10.1095\/biolreprod44.6.1183"},{"key":"2022061620195812300_B23","doi-asserted-by":"crossref","unstructured":"Yang D. H., Smith E. R., Cohen C., Wu H., Patriotis C., Godwin A. K., et al Molecular events associated with dysplastic morphologic transformation and initiation of ovarian tumorigenicity. Cancer (Phila.), 94:\u20082380-2392, \u20082002.","DOI":"10.1002\/cncr.10497"},{"key":"2022061620195812300_B24","doi-asserted-by":"crossref","unstructured":"Capo-Chichi C. D., Smith E. R., Yang D-H., Roland I. H., Vanderveer L., Cohen C., Hamilton T. C., Godwin A., Xu X-X. Dynamic alterations of the extracellular environment of ovarian surface epithelial cells in premalignant transformation, tumorigenicity, and metastasis. Cancer (Phila.), 95:\u20081802-1815, \u20082002.","DOI":"10.1002\/cncr.10870"},{"key":"2022061620195812300_B25","doi-asserted-by":"crossref","unstructured":"Roland I. H., Yang W-L., Yang D-H., Daly M. B., Ozols R. F., Hamilton T. C., Godwin A. K., Xu X-X. Loss of surface and cyst epithelial basement membranes and pre-neoplastic morphological changes in prophylactic oophorectomies. Cancer, 98:\u20082607-2623, \u20082003.","DOI":"10.1002\/cncr.11847"},{"key":"2022061620195812300_B26","doi-asserted-by":"crossref","unstructured":"Dano K., Andreasen P. A., Grondahl-Hansen J., Kristensen P., Nielsen L. S., Skriver L. Plasminogen activators, tissue degradation, and cancer. Adv. Cancer Res., 44:\u2008139-266, \u20081985.","DOI":"10.1016\/S0065-230X(08)60028-7"},{"key":"2022061620195812300_B27","doi-asserted-by":"crossref","unstructured":"Ny T., Wahlberg P., Brandstrom I. J. Matrix remodeling in the ovary: regulation and functional role of the plasminogen activator and matrix metalloproteinase systems. Mol. Cell. Endocrinol., 187:\u200829-38, \u20082002.","DOI":"10.1016\/S0303-7207(01)00711-0"},{"key":"2022061620195812300_B28","doi-asserted-by":"crossref","unstructured":"Stack M. S., Ellerbroek S. M., Fishman D. A. The role of proteolytic enzymes in the pathology of epithelial ovarian carcinoma. Int. J. Oncol., 12:\u2008569-576, \u20081998.","DOI":"10.3892\/ijo.12.3.569"},{"key":"2022061620195812300_B29","doi-asserted-by":"crossref","unstructured":"Stracke J. O., Hutton M., Stewart M., Pendas A. M., Smith B., Lopez-Otin C., Murphy G., Knauper V. Biochemical characterization of the catalytic domain of human matrix metalloproteinase 19. Evidence for a role as a potent basement membrane degrading enzyme. J. Biol. Chem., 275:\u200814809-14816, \u20082000.","DOI":"10.1074\/jbc.275.20.14809"},{"key":"2022061620195812300_B30","doi-asserted-by":"crossref","unstructured":"Ramos-DeSimone N., Hahn-Dantona E., Sipley J., Nagase H., French D. L., Quigley J. P. Activation of matrix metalloproteinase-9 (MMP-9) via a converging plasmin\/stromelysin-1 cascade enhances tumor cell invasion. J. Biol. Chem., 274:\u200813066-13076, \u20081999.","DOI":"10.1074\/jbc.274.19.13066"},{"key":"2022061620195812300_B31","unstructured":"Jankun J., Skrzypczak-Jankun E. Molecular basis of specific inhibition of urokinase plasminogen activator by amiloride. Cancer Biochem. Biophys., 17:\u2008109-123, \u20081999."},{"key":"2022061620195812300_B32","doi-asserted-by":"crossref","unstructured":"Yang W-L., Frucht H. Activation of PPAR pathway induces apoptosis and COX-2 inhibition in HT-29 human colon cancer cells. Carcinogenesis (Lond.), 22:\u20081379-1383, \u20082001.","DOI":"10.1093\/carcin\/22.9.1379"},{"key":"2022061620195812300_B33","doi-asserted-by":"crossref","unstructured":"Reich R., Martin G. R. Identification of arachidonic acid pathways required for the invasive and metastatic activity of malignant tumor cells. Prostaglandins, 51:\u20081-17, \u20081996.","DOI":"10.1016\/0090-6980(95)00154-9"},{"key":"2022061620195812300_B34","doi-asserted-by":"crossref","unstructured":"Bond M., Rosalind P., Fabunmi P., Baker A. H., Newby A. C. Synergistic upregulation of metalloproeinase-9 by growth factors and inflammatory cytokines: an absolute requirement for transcription factor NF-kappa B. FEBS Lett., 435:\u200829-34, \u20081998.","DOI":"10.1016\/S0014-5793(98)01034-5"},{"key":"2022061620195812300_B35","doi-asserted-by":"crossref","unstructured":"Haddad J. J., Land S. C. Amiloride blockages lipopolsaccharide-induced proinflammatory cytokine biosynthesis in an IkB-\u03b1\/Nf-kb-dependent mechanism. Am. J. Respir. Cell Mol. Biol., 26:\u2008114-126, \u20082002.","DOI":"10.1165\/ajrcmb.26.1.4657"},{"key":"2022061620195812300_B36","doi-asserted-by":"crossref","unstructured":"Fathalla M. F. Incessant ovulation\u2013a factor in ovarian neoplasia?. Lancet, 2:\u2008163\u20081971.","DOI":"10.1016\/S0140-6736(71)92335-X"},{"key":"2022061620195812300_B37","unstructured":"Cramer D. W., Welch W. R. Determinants of ovarian cancer risk. II. Inferences regarding pathogenesis. J. Natl. Cancer Inst. (Bethesda), 71:\u2008717-721, \u20081983."},{"key":"2022061620195812300_B38","doi-asserted-by":"crossref","unstructured":"Pfeilschifter J., Koditz R., Pfohl M., Schatz H. Changes in proimflammatory cytokine activity after menopause. Endocr. Rev., 23:\u200890-119, \u20082002.","DOI":"10.1210\/edrv.23.1.0456"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/64\/4\/1534\/2522516\/zch00404001534.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/64\/4\/1534\/2522516\/zch00404001534.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T21:35:53Z","timestamp":1655415353000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/64\/4\/1534\/512210\/Tumor-Necrosis-Factor-Induced-Matrix-Proteolytic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,2,15]]},"references-count":38,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2004,2,18]]},"published-print":{"date-parts":[[2004,2,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-03-2928","relation":{},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,2,15]]}}}